Trials / Unknown
UnknownNCT00315107
Estrogen Treatment in Acromegalic Women
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Université de Montréal · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
Detailed description
This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptimal response to sandostatin LAR treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alesse |
Timeline
- Start date
- 2006-05-01
- Completion
- 2007-08-01
- First posted
- 2006-04-17
- Last updated
- 2006-05-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00315107. Inclusion in this directory is not an endorsement.